Promoteur(s) :
Abramson Cancer Center at Penn Medicine
Recrutement : fermé
Centres participants
3
Dernière modification : 2026-01-28
DESCRIPTION DE L'ÉTUDE
Résumé de l'étude
This trial is designed to be the initial prospective pilot investigation of the effectiveness of combined SBRT and TACE as bridging therapy for HCC patients awaiting liver transplanation. No prospective clinical trials regarding the combination of TACE and SBRT in pre-transplant population have been performed. We propose the trial be conducted as a pilot clinical trial with the goal of enrolling 40 patients into each arm
Source : Importé depuis le centre
The purpose of this study is to determine whether the combination of stereotatic body radiotherapy (SBRT) tand transarterial chemoembolization (TACE) is an effective "bridging therapy" for patients hepatocellular carcinoma (HCC) of the liver awaiting transplantation.
Source : Importé depuis le centre
RECRUTEMENT
Profil des participants
Limites d'âge
minimum : 18 ans
Sexe(s) des participants
ALL
Source : Importé depuis le centre
Condition médicale (spécialité visée)
Domaine de recherche
Donnée non disponible
Critères de sélection
Cohortes
Nom
Condition médicale
Traitement
État du recrutement
A -Tace alone
A - TACE alone (control group, current practice and treatment)
Donnée non disponible
Inconnu
B - Tace combined with SBRT
B- TACE combined with SBRT (experimental group).
Donnée non disponible
Inconnu
A -Tace alone
État du recrutement
unknown
A - TACE alone (control group, current practice and treatment)
B - Tace combined with SBRT
État du recrutement
unknown
B- TACE combined with SBRT (experimental group).
Données à jour depuis :
28 janvier 2026
SITES ET CONTACTS
Centre principal
loyola university medical center
MAYWOOD, ILLINOIS, UNITED STATES
Recrutement local
—
FERMÉ
Aussi disponible à: PORTLAND, (OREGON), PHILADELPHIA, (PENNSYLVANIA)
Dernière modification :
28 janvier 2026
Données à jour depuis :
30 jan.
Origine des données :
clinicaltrials.gov
* Patient capable of giving informed consent
* Patient diagnosed with hepatocellular carcinoma and listed or recommended to be listed for orthotopic liver transplantation at the participating institution
* Age \> 18 years old
* Meets clinical criteria for eligibility for TACE to the target lesion per Interventional Radiology
* Childs' Class A or B7
* Eastern Clinical Oncology Group performance status 0 or 1
Exclusion Criteria:
* Prior radiotherapy to the upper abdomen or radioembolization of the liver
* Prior TACE to the target lesion, RFA, or liver transplant
* Active GI bleed within 2 weeks of study enrollment
* Active GI ulcer disease within 4 weeks of study enrollment
* Ascites refractory to medical therapy
* Contraindication to receiving radiotherapy or TACE
* Complete obstruction of portal venous flow to the segment of liver that includes the target lesion
* Contraindication to both contrast enhanced MRI and contrast enhanced CT (i.e. unable to undergo follow-up imaging or SBRT treatment planning)
* Women who are pregnant
* Participation in another concurrent treatment protocol
Source : Importé depuis le centre
Cohortes
Thérapie ou Intervention proposée
Cohortes
Nom
Condition médicale
Traitement
État du recrutement
A -Tace alone
A - TACE alone (control group, current practice and treatment)
Donnée non disponible
Inconnu
B - Tace combined with SBRT
B- TACE combined with SBRT (experimental group).
Donnée non disponible
Inconnu
A -Tace alone
État du recrutement
unknown
A - TACE alone (control group, current practice and treatment)
B - Tace combined with SBRT
État du recrutement
unknown
B- TACE combined with SBRT (experimental group).
Données à jour depuis :
28 janvier 2026
Description de l'étude
Description de l'étude
Résumé de l'étude
This trial is designed to be the initial prospective pilot investigation of the effectiveness of combined SBRT and TACE as bridging therapy for HCC patients awaiting liver transplanation. No prospective clinical trials regarding the combination of TACE and SBRT in pre-transplant population have been performed. We propose the trial be conducted as a pilot clinical trial with the goal of enrolling 40 patients into each arm
Source : Importé depuis le centre
The purpose of this study is to determine whether the combination of stereotatic body radiotherapy (SBRT) tand transarterial chemoembolization (TACE) is an effective "bridging therapy" for patients hepatocellular carcinoma (HCC) of the liver awaiting transplantation.
Source : Importé depuis le centre
Centres participants
Sites
Centres participants
3
centres
ABRAMSON CANCER CENTER OF THE UNIVERSITY OF PENNSYLVANIA
Philadelphia
PENNSYLVANIA, UNITED STATES
Recrutement local
État du recrutement:
FERMÉ
LOYOLA UNIVERSITY MEDICAL CENTER
Maywood
ILLINOIS, UNITED STATES
Recrutement local
État du recrutement:
FERMÉ
OREGON HEALTH & SCIENCE UNIVERSITY
Portland
OREGON, UNITED STATES
Recrutement local
État du recrutement:
FERMÉ
Source d'information
Dernière modification :
28 janvier 2026
Données à jour depuis :
30 jan.
Origine des données :
clinicaltrials.gov